Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Metabolic control analysis of hepatic glycogen synthesis in vivo.

Yuichi Nozaki | Max C Petersen | Dongyan Zhang | Daniel F Vatner | Rachel J Perry | Abudukadier Abulizi | Sofie Haedersdal | Xian-Man Zhang | Gina M Butrico | Varman T Samuel | Graeme F Mason | Gary W Cline | Kitt F Petersen | Douglas L Rothman | Gerald I Shulman
Proceedings of the National Academy of Sciences of the United States of America | 2020

Multiple insulin-regulated enzymes participate in hepatic glycogen synthesis, and the rate-controlling step responsible for insulin stimulation of glycogen synthesis is unknown. We demonstrate that glucokinase (GCK)-mediated glucose phosphorylation is the rate-controlling step in insulin-stimulated hepatic glycogen synthesis in vivo, by use of the somatostatin pancreatic clamp technique using [13C6]glucose with metabolic control analysis (MCA) in three rat models: 1) regular chow (RC)-fed male rats (control), 2) high fat diet (HFD)-fed rats, and 3) RC-fed rats with portal vein glucose delivery at a glucose infusion rate matched to the control. During hyperinsulinemia, hyperglycemia dose-dependently increased hepatic glycogen synthesis. At similar levels of hyperinsulinemia and hyperglycemia, HFD-fed rats exhibited a decrease and portal delivery rats exhibited an increase in hepatic glycogen synthesis via the direct pathway compared with controls. However, the strong correlation between liver glucose-6-phosphate concentration and net hepatic glycogen synthetic rate was nearly identical in these three groups, suggesting that the main difference between models is the activation of GCK. MCA yielded a high control coefficient for GCK in all three groups. We confirmed these findings in studies of hepatic GCK knockdown using an antisense oligonucleotide. Reduced liver glycogen synthesis in lipid-induced hepatic insulin resistance and increased glycogen synthesis during portal glucose infusion were explained by concordant changes in translocation of GCK. Taken together, these data indicate that the rate of insulin-stimulated hepatic glycogen synthesis is controlled chiefly through GCK translocation.

Pubmed ID: 32188779

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001863
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK114793
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK116774
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK108283
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK119968
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK045735
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK034989
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK113984
  • Agency: NIAAA NIH HHS, United States
    Id: R01 AA021984

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Cell Signaling Technology (tool)

RRID:SCR_004431

Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.

View all literature mentions

New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions

SD (tool)

RRID:RGD_70508

Rattus norvegicus with name SD from RGD.

View all literature mentions